Security key
09077V100
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)
CUSIP: 09077V100
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 317
- Total 13F value
- $7,770
- Share change
- -98
- SEC-reported price per share
- $24.51
- Number of holders
- 3
- Value change
- -$2,403
- Number of sells
- 2
- Shares outstanding
- 44,967,550
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
3
Top holders
3
BIOA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
BioAge Labs, Inc. SEC filings
BioAge Labs, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09077V100
Recent filing periods:
Ownership snapshot
Top reported holders of BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kristen Fortney
Disclosed value leader
a16z Capital Management, ...
Comparable rows
15/15
Latest evidence
15 May 2026
13D/G
3/4/5
13F
Lead comparable stake: 7.2%
13D/G row: Kristen Fortney
Showing 1-6 of 15 holder rows.
Quick read
Kristen Fortney leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kristen Fortney's linked filing trail.
Comparable ownership
Top 5
Kristen Fortney
7.2%
Cormorant Asset Management, LP
6.5%
BlackRock, Inc.
5%
Khosla Ventures VI, L.P.
4%
RA CAPITAL MANAGEMENT, L.P.
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kristen Fortney |
13D/G
3/4/5
Chief Executive Officer, Director
|
7.2%
|
$48,279,538
2,704,736 shares
|
$0 | 31 Dec 2025 |
| Cormorant Asset Management, LP |
13F
13D/G
3/4/5
Company · Former 10% Owner
|
6.5%
from 13D/G
|
$50,556,681
2,890,605 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5%
from 13D/G
|
$39,663,052
2,267,756 shares
|
— | 31 Mar 2026 |
| Khosla Ventures VI, L.P. |
13D/G
VK Services, LLC
|
4%
|
$29,120,985
1,798,702 shares
|
$0 | 15 May 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
Company
|
3.7%
from 13D/G
|
$28,869,834
1,650,648 shares
|
— | 31 Mar 2026 |
| ADAR1 Capital Management, LLC |
13D/G
13F
Company
|
0.4%
|
$2,419,746
135,560 shares
|
-$32,157,900 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
317
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
144
Q2 2026 holders
3
Holder diff
-141
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend